Quarterly report [Sections 13 or 15(d)]

SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)

v3.26.3
SCHEDULE OF STOCK OPTIONS ACTIVITY (Details) - USD ($)
 3 Months Ended 12 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Equity [Abstract]    
Number of Shares, Outstanding, beginning balance 928,882 796,660
Weighted Average Exercise Price, Outstanding, beginning balance $ 3.06 $ 4.10
Weighted Average Grant Date Fair Value, beginning balance $ 2.20 $ 3.08
Number of Shares, Granted 222,222 536,239
Weighted Average Exercise Price, Granted $ 1.08 $ 1.88
Weighted Average Grant Date Fair Value, Granted $ 0.14 $ 1.23
Number of Shares, Exercised (62,125)
Weighted Average Exercise Price, Exercised   $ 4.10
Weighted Average Grant Date Fair Value, Exercised   $ 3.40
Number of Shares, Forfeited and cancelled (90,247) (341,892)
Weighted Average Exercise Price, Forfeited and cancelled $ 2.55 $ 3.43
Aggregate intrinsic Value, Exercised   $ 115,095
Weighted Average Grant Date Fair Value, Forfeited and cancelled $ 1.75 $ 2.53
Aggregate intrinsic Value, Outstanding $ 0.00  
Weighted Average Remaining Contract Term (years), Granted 9 years 6 months  
Number of Shares, Outstanding, ending balance 1,060,857 928,882
Weighted Average Exercise Price, Outstanding, ending balance $ 2.69 $ 3.06
Weighted Average Remaining Contract Term (years), Outstanding 7 years 10 months 24 days  
Aggregate intrinsic Value, Outstanding $ 0.00 $ 0.00
Weighted Average Grant Date Fair Value, ending balance $ 1.81 $ 2.20
Number of Shares, Exercisable, ending balance 542,970  
Weighted Average Exercise Price, Exercisable, ending balance $ 3.44  
Weighted Average Remaining Contract Term (years), exercisable 5 years 4 months 24 days  
Aggregate intrinsic Value, Exercisable $ 0.00  
Weighted Average Grant Date Fair Value, Exercisable $ 2.52